FABP4 and cancer: A longitudinal community-based Cardiovascular Risk Factors Prevalence Study (CRISPS) in human subjects from Hong Kong shows that IL-6, soluble tumor necrosis factor receptor 2 (sTNFR2; as a surrogate marker of tumor necrosis factor-α activity), leptin, lipocalin 2, adiponectin, and adipocyte-fatty acid binding protein (A-FABP) are predictors for cancer development [10–12].